VP

Ved Prakash Agarwal

Active Director Director DIN 10127906
DIN 10127906 First appointment Apr 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2023
Shareholding value •••• Premium profile

About Ved Prakash Agarwal

Data last updated:

Ved Prakash Agarwal is a Director at Darwincure Healthcare Private Limited (since 2023). Darwincure Healthcare Private Limited reported revenue of ₹3.97 Cr (FY 2025).

DIN 10127906
Primary Designation Director
First Appointment 21 Apr 2023
Oldest Company Age 3 yrs
Largest company Darwincure Healthcare Private Limited · ₹3.97 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Apr 20232023₹3.97 Cr (FY 2025)Active

Board colleagues of Ved Prakash Agarwal

NameDINCompanyDesignation
Neha Agarwal10127905Darwincure Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Darwincure Healthcare Private Limited
Premium access

Shareholding and investment profile for Ved Prakash Agarwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ved Prakash Agarwal

Ved Prakash Agarwal currently holds 1 directorship: Darwincure Healthcare Private Limited (Director, since 21 Apr 2023, revenue ₹3.97 Cr (FY 2025)).

Ved Prakash Agarwal was first appointed on 21 Apr 2023 as Director at Darwincure Healthcare Private Limited.

The current boards of Ved Prakash Agarwal's companies include Neha Agarwal (Darwincure Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available